Teva Pharmaceutical Industries Ltd. (TEVA) fell the most since October in Tel Aviv, narrowing the gap with its U.S.-traded shares.
The stock of the world’s largest generic drugmaker dropped 3.6 percent, the biggest decline since Oct. 4, to 150.40 shekels, or the equivalent of $39.33, at the close in Tel Aviv. Teva’s stock in New York fell 7 percent last week to close at $38.90 on May 18.
To contact the reporter on this story: David Wainer in Tel Aviv at email@example.com
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org